id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-V-3373-0003,FDA,FDA-2022-V-3373,Variance Approval Letter from FDA CDRH to 4Grand Entertainment,Other,Approval for Variance (VRA),2023-02-24T05:00:00Z,2023,2,2023-02-24T05:00:00Z,,2023-02-24T18:37:27Z,,0,0,09000064857011ba
FDA-2022-V-3373-0001,FDA,FDA-2022-V-3373,Variance Application from 4Grand Entertainment,Other,Application for Variance (VAR),2022-12-29T05:00:00Z,2022,12,2022-12-29T05:00:00Z,,2022-12-29T13:36:55Z,,0,0,090000648555b322
FDA-2022-V-3373-0002,FDA,FDA-2022-V-3373,Acknowledgment Letter from FDA DMS to 4Grand Entertainment,Other,Acknowledgement Letter/Receipt,2022-12-29T05:00:00Z,2022,12,2022-12-29T05:00:00Z,,2022-12-29T13:41:05Z,,0,0,090000648555b32d